Current role
General Counsel
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Sarepta Therapeutics, Inc. (SRPT)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Sarepta Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Douglas Ingram CEO, Board Member
- Michael Severino, M.D. CEO, Board Member
- M. Kathleen Behrens Chairman
- Ryan H. Wong CFO
- Ian Estepan COO, Chief Accounting Officer
- Ian M. Estepan COO
- Cristin L. Rothfuss General Counsel
- Claude Nicaise Board Member
- Claude Nicaise, M.D. Board Member
- Deirdre Connelly Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Sarepta Therapeutics, Inc. (SRPT) | Former Officer | — | — |
| 2019 | Sarepta Therapeutics, Inc. (SRPT) | ^^ Former Officer | — | — |
Recent activity
No call appearances or filed executive changes recorded yet.